ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,487.40
0.12%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Recursion Pharmaceuticals Inc (RXRX)

  7. Recursion Pharmaceuticals Inc (RXRX) 뉴스

RXRX Recursion Pharmaceuticals Inc

8.12
0.28 (3.57%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Recursion Pharmaceuticals Inc RXRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.28 3.57% 8.12 13:00:08
개장가 저가 고가 종가 전일 종가
7.86 7.68 8.1391 8.12 7.84
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202421:00GLOBERecursion Appoints Najat Khan, PhD, as Chief R&D Officer and..
02/04/202421:00GLOBERecursion to Participate in Upcoming Investor Conference
26/03/202421:00GLOBERecursion Publishes Annual Environmental, Social and..
11/03/202417:00GLOBERecursion Announces Plans to Open New Office in London
09/03/202409:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:39EDGAR2Form 144 - Report of proposed sale of securities
07/03/202406:59EDGAR2Form 144 - Report of proposed sale of securities
06/03/202406:18EDGAR2Form 144 - Report of proposed sale of securities
02/03/202404:58GLOBERecursion Hosts Second Annual Rare Disease Day Events for..
01/03/202421:59GLOBERecursion to Participate in Upcoming Investor Conferences
29/02/202422:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202406:05GLOBERecursion Provides Business Updates and Reports Fourth..
24/02/202409:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202408:13EDGAR2Form 144 - Report of proposed sale of securities
22/02/202407:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:29EDGAR2Form 144 - Report of proposed sale of securities
20/02/202421:59GLOBERecursion to Host Public L(earnings) Call on February 27
17/02/202409:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202409:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202409:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:50EDGAR2Form 144 - Report of proposed sale of securities
14/02/202409:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:18EDGAR2Form 144 - Report of proposed sale of securities
13/02/202402:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/02/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202407:13EDGAR2Form 144 - Report of proposed sale of securities
08/02/202406:56EDGAR2Form 8-K - Current report
07/02/202406:12EDGAR2Form 144 - Report of proposed sale of securities
01/02/202406:40EDGAR2Form 8-K - Current report
30/01/202408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202406:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/01/202408:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:23EDGAR2Form 144 - Report of proposed sale of securities
24/01/202423:00GLOBEAltitude Lab Startups Raise Over $120M in Capital
24/01/202406:20EDGAR2Form 144 - Report of proposed sale of securities
19/01/202408:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:34EDGAR2Form 144 - Report of proposed sale of securities
17/01/202406:14EDGAR2Form 144 - Report of proposed sale of securities
16/01/202423:55EDGAR2Form 144 - Report of proposed sale of securities
12/01/202408:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202407:02EDGAR2Form 144 - Report of proposed sale of securities
10/01/202406:15EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
RXRX
Recursion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유